Viewing nowRemist Tablets (Rebamipide)
Rebamipide 100mg
Tablet · Prescription medication
Hawon Pharmaceutical Co., Ltd.

MFDS item code 200302050 · Notified 2003.11.19 · Insurance code 651500260
Improvement of gastric ulcers and gastric mucosal lesions (erosion, bleeding, etc.)
This medication is effective in the treatment of gastric ulcers and is used to improve mucosal lesions such as erosion, bleeding, redness, and edema that occur during acute exacerbations of acute and chronic gastritis.
For rebamipide, take 100 mg orally three times a day. However, for gastric ulcers, administer in the morning, evening, and before bedtime.
This medication should not be used in patients with a history of hypersensitivity to any of its components. Rarely, serious allergic reactions such as shock or anaphylaxis can occur when taking this medication, so if symptoms appear, treatment should be discontinued immediately and appropriate medical intervention should be sought. White blood cell or platelet count may decrease, so it is important to monitor blood status periodically. If there are abnormal liver function test results, the use of this medication should be discontinued as it may cause liver dysfunction. Skin hypersensitivity reactions such as urticaria, rash, and itching may occur, so use should be discontinued immediately if these symptoms arise. This medication can cause neurological symptoms such as dizziness, drowsiness, and numbness, so caution is needed when driving or operating machinery. Gastrointestinal symptoms may include dry mouth, constipation, abdominal bloating, diarrhea, nausea, vomiting, heartburn, and abdominal pain, and if discomfort persists, consult a doctor. Women who are pregnant or may become pregnant should consult a doctor before taking this medication, and breastfeeding women should avoid nursing while on this medication. Caution is needed when using this medication in children, especially in low birth weight infants, neonates, and infants, as safety has not been fully established. In elderly patients, the incidence of adverse reactions is not significantly different from that in the general adult population, but they may have reduced physical functions, thus requiring special caution regarding gastrointestinal symptoms. This medication should be kept out of the reach of children and should not be transferred to another container as this may cause degradation of quality or accidents.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to light, and should be stored in a tightly closed container that blocks light. Additionally, it is best to store the medication at a temperature between 1°C to 30°C (33.8°F to 86°F). By storing it this way, the medication's efficacy can be maintained.
White round film-coated tablets
30 tablets/bottle, 500 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRebamipide 100mg
Tablet · Prescription medication
Hawon Pharmaceutical Co., Ltd.

Rebamipide 100mg
Tablet · Prescription medication
Korea Otsuka Pharmaceutical Co., Ltd.

Rebamipide 100mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Rebamipide 100mg
Tablet · Prescription medication
Sinphong Pharmaceutical Co., Ltd.

Rebamipide 100mg
Tablet · Prescription medication
Yuhan Corporation

Rebamipide 100mg
Tablet · Prescription medication
Jongkundang Corporation

Rebamipide 100mg
Tablet · Prescription medication
Donghwa Pharmaceutical Co., Ltd.

Rebamipide 100mg
Tablet · Prescription medication
Sama Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.